Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia

Clinica Chimica Acta; International Journal of Clinical Chemistry
H NandeeshaS K Sen

Abstract

BPH is a multifactorial disease. Several studies have elucidated the role of hormones and growth factors in its etiology. Insulin is a growth-stimulating hormone. Previous studies have reported the association between hyperinsulinemia, dyslipidemia and BPH in patients with metabolic disorders like diabetes. We evaluated insulin and lipid profile parameters in non-diabetic BPH cases and correlated it with prostate size. 50 symptomatic BPH cases and 38 controls were included in this study. Fasting serum insulin concentrations were measured by radioimmunoassay. Insulin resistance was assessed by HOMA. Fasting glucose, total cholesterol and triglycerides were quantified by enzymatic methods. HDL-cholesterol was quantified by phosphotungstate magnesium chloride method. LDL-cholesterol was calculated by Friedwald's formula. Fasting serum insulin, HOMA, total cholesterol, and LDL-cholesterol were significantly higher and HDL-cholesterol was significantly lower in cases as compared to controls. Insulin was significantly associated with prostate size, cholesterol, triglycerides, VLDL-cholesterol and LDL-cholesterol in BPH cases. Stepwise regression analysis showed insulin as an independent risk factor in the development of BPH. Hyperins...Continue Reading

References

Mar 1, 1995·Microscopy Research and Technique·F SinowatzG Boos
Sep 21, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·S M Haffner
Sep 21, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·A Hautanen
Oct 26, 2000·Current Opinion in Lipidology·M SakaiS Horiuchi
Apr 6, 2001·Diabetes Care·K A McAuleyA W Duncan
Dec 26, 2001·Urology·S J JacobsenM M Lieber
Jul 18, 2002·European Urology·Claus G RoehrbornUNKNOWN PLESS Study Group. Proscar Long-term Efficacy and Safety Study
Jan 2, 2003·Journal of the National Cancer Institute·Ann W HsingFrank Z Stanczyk

❮ Previous
Next ❯

Citations

Feb 5, 2008·International Urology and Nephrology·H Nandeesha
Jul 3, 2009·Current Urology Reports·Anne K Mongiu, Kevin T McVary
Jul 3, 2009·Current Urology Reports·Aruna V Sarma, J Kellogg Parsons
Aug 4, 2011·Nature Reviews. Urology·Jan Hammarsten, Ralph Peeker
Oct 1, 2008·Prostate Cancer and Prostatic Diseases·J HammarstenD Mellström
Feb 20, 2008·Prostate Cancer and Prostatic Diseases·R J BarnardW J Aronson
Nov 21, 2012·Prostate Cancer and Prostatic Diseases·M GacciM Maggi
Nov 12, 2009·Current Opinion in Urology·Samdeep Moul, Kevin T McVary
Oct 8, 2014·Current Urology Reports·Benjamin N Breyer, Aruna V Sarma
Apr 9, 2011·Current Bladder Dysfunction Reports·J Kellogg Parsons
Jan 13, 2016·Nature Reviews. Urology·Linda VignozziMario Maggi
Oct 15, 2013·Clinical Genitourinary Cancer·Chin-Hsiao Tseng
Feb 13, 2013·The Journal of Urology·Mohammad-Ali HaghshenoJan Hammarsten
Sep 24, 2011·Differentiation; Research in Biological Diversity·Barry G Timms, Luke E Hofkamp
Jun 8, 2011·Differentiation; Research in Biological Diversity·Ming JiangSimon W Hayward
May 4, 2011·Differentiation; Research in Biological Diversity·Zongwei Wang, Aria F Olumi
Dec 17, 2010·Medical Hypotheses·Ajit Vikram, Gopabandhu Jena
Oct 14, 2010·European Journal of Pharmacology·Ajit VikramPoduri Ramarao
Jun 18, 2010·European Journal of Pharmacology·Ajit VikramPoduri Ramarao
Jul 4, 2008·Urology·Hyoung Keun ParkUNKNOWN Korean Longitudinal Study on Health and Aging
Oct 24, 2007·Toxicology and Applied Pharmacology·A VikramG B Jena
Apr 25, 2007·European Urology·Steven A Kaplan
Jul 22, 2015·International Journal of Urology : Official Journal of the Japanese Urological Association·Giorgio I RussoGiuseppe Morgia
Nov 17, 2007·BJU International·J Kellogg ParsonsElizabeth Barrett-Connor
Mar 1, 2012·Lower Urinary Tract Symptoms·Hwancheol SonWon Hee Park
Apr 30, 2015·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Benjamin C TrumbleMichael D Gurven
Dec 19, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Reshu TewariSingh Rajender
Nov 15, 2011·Scandinavian Journal of Urology and Nephrology·C GratzkeM Siebels
Apr 2, 2014·International Journal of Endocrinology·Giovanni CoronaMario Maggi

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.